Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Manenti, M. Gariboldi, A. Fiorino, A. Zedda, M. Pierotti, T. Dragani (2009)
Pas1 is a common lung cancer susceptibility locus in three mouse strainsMammalian Genome, 8
G. Stathopoulos, T. Sherrill, D. Cheng, R. Scoggins, W. Han, V. Polosukhin, L. Connelly, F. Yull, B. Fingleton, T. Blackwell (2007)
Epithelial NF-κB activation promotes urethane-induced lung carcinogenesisProceedings of the National Academy of Sciences, 104
M. Maemondo, Y. Saijo, K. Narumi, T. Kikuchi, K. Usui, R. Tazawa, Kunio Matsumoto, Toshikazu Nakamura, K. Sasaki, Minoru Takahashi, Y. Niitsu, T. Nukiwa (2004)
Gene Therapy with Secretory Leukoprotease Inhibitor Promoter-Controlled Replication-Competent Adenovirus for Non-Small Cell Lung CancerCancer Research, 64
S. Belinsky, T. Devereux, Julie Foley, Robert Maronpot, M. Anderson (1992)
Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse.Cancer research, 52 11
S. Kawamoto, A. Kirschbaum, M. Ibanez, J. Trentin, H. Taylor (1961)
Influence of urethan on the development of spontaneous leukemia and on the induction of hemagiomas in the AKR and C58 strains of mice.Cancer research, 21
F. Jin, C. Nathan, D. Radzioch, A. Ding (1997)
Secretory Leukocyte Protease Inhibitor: A Macrophage Product Induced by and Antagonistic to Bacterial LipopolysaccharideCell, 88
A. Malkinson (1998)
Molecular comparison of human and mouse pulmonary adenocarcinomas.Experimental lung research, 24 4
P. Donnelly, T. Massey (1999)
Ki‐ras activation in lung cells isolated from AC3F1 (A/J×C3H/HeJ) mice after treatment with aflatoxin B1Molecular Carcinogenesis, 26
Rinat Zaynagetdinov, G. Stathopoulos, T. Sherrill, D. Cheng, A. McLoed, Jamie Ausborn, V. Polosukhin, L. Connelly, Weisong Zhou, B. Fingleton, Peebles Rs, L. Prince, F. Yull, T. Blackwell (2011)
EPITHELIAL NUCLEAR FACTOR-κB SIGNALING PROMOTES LUNG CARCINOGENESIS VIA RECRUITMENT OF REGULATORY T LYMPHOCYTESOncogene, 31
Konstantinos Doris, Sophia Karabela, Chrysoula Kairi, D. Simoes, C. Roussos, S. Zakynthinos, I. Kalomenidis, T. Blackwell, G. Stathopoulos (2010)
Allergic inflammation does not impact chemical-induced carcinogenesis in the lungs of miceRespiratory Research, 11
Fiona Simpkins, N. Devoogdt, N. Rasool, N. Tchabo, E. Alejandro, Michael Kamrava, E. Kohn (2007)
The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells.Carcinogenesis, 29 3
G. Ashcroft, K. Lei, W. Jin, G. Longenecker, A. Kulkarni, T. Greenwell-Wild, H. Hale‐Donze, G. McGrady, Xiao-yu Song, S. Wahl (2000)
Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healingNature Medicine, 6
S. Ameshima, T. Ishizaki, Y. Demura, Y. Imamura, I. Miyamori, H. Mitsuhashi (2000)
Increased secretory leukoprotease inhibitor in patients with nonsmall cell lung carcinomaCancer, 89
D. Maria, G. Manenti, F. Galbiati, O. Ribeiro, W. Cabrera, R. Barrera, Angela Pettinicchio, Marcelo Franco, N. Starobinas, M. Siqueira, T. Dragani, O. Ibañez (2003)
Pulmonary adenoma susceptibility 1 (Pas1) locus affects inflammatory responseOncogene, 22
M. Festing, Aili Yang, A. Malkinson (1994)
At least four genes and sex are associated with susceptibility to urethane-induced pulmonary adenomas in mice.Genetical research, 64 2
Stanfield Rogers (1951)
AGE OF THE HOST AND OTHER FACTORS AFFECTING THE PRODUCTION WITH URETHANE OF PULMONARY ADENOMAS IN MICEThe Journal of Experimental Medicine, 93
A. Vroling, T. Konijn, J. Samsom, G. Kraal (2011)
The production of secretory leukocyte protease inhibitor by dendritic cells.Molecular immunology, 48 4
N. Shine, Susan Wang, K. Konopka, E. Burks, N. Düzgüneş, C. Whitman (2002)
Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein.Bioorganic chemistry, 30 4
L. Qiao, Jun Yu, P. Dent, G. Farrell (2005)
NF-κB protects rat ARL-6 hepatocellular carcinoma cells against hydrogen peroxide-induced apoptosisCancer Biology & Therapy, 4
Takuji Suzuki, T. Fukuhara, Masashi Tanaka, A. Nakamura, Kenichi Akiyama, Tomohiro Sakakibara, D. Koinuma, T. Kikuchi, R. Tazawa, M. Maemondo, K. Hagiwara, Y. Saijo, T. Nukiwa (2005)
Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.Clinical cancer research : an official journal of the American Association for Cancer Research, 11 1
A. Su, T. Wiltshire, S. Batalov, H. Lapp, K. Ching, David Block, Jie Zhang, R. Soden, M. Hayakawa, Gabriel Kreiman, M. Cooke, J. Walker, J. Hogenesch (2004)
A gene atlas of the mouse and human protein-encoding transcriptomes.Proceedings of the National Academy of Sciences of the United States of America, 101 16
K. Viswanath, R. Herbst, S. Land, S. Leischow, P. Shields (2010)
Tobacco and cancer: an American Association for Cancer Research policy statement.Cancer research, 70 9
G. Pfeifer, M. Denissenko, M. Olivier, N. Tretyakova, S. Hecht, P. Hainaut (2002)
Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancersOncogene, 21
A. Bauer, A. Malkinson, S. Kleeberger (2004)
Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities.American journal of physiology. Lung cellular and molecular physiology, 287 4
S. Dasgupta, P. Tripathi, Hongxing Qin, M. Bhattacharya‐Chatterjee, J. Valentino, S. Chatterjee (2006)
Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma.Oral oncology, 42 3
H. Bernert, K. Sekikawa, R. Radcliffe, F. Iraqi, M. You, A. Malkinson (2003)
Tnfa and Il‐10 deficiencies have contrasting effects on lung tumor susceptibility: Gender‐dependent modulation of IL‐10 haploinsufficiencyMolecular Carcinogenesis, 38
D. Tuveson, T. Jacks (1999)
Modeling human lung cancer in mice: similarities and shortcomingsOncogene, 18
N. Devoogdt, Gholamreza Ghassabeh, Jing Zhang, L. Brys, P. Baetselier, H. Revets (2003)
Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cellsProceedings of the National Academy of Sciences of the United States of America, 100
G. Biozzi, O. Ribeiro, A. Saran, M. Araújo, D. Maria, M. Franco, W. Cabrera, O. Sant'Anna, S. Massa, V. Covelli, D. Mouton, T. Neveu, M. Siqueira, O. Ibañez (1998)
Effect of genetic modification of acute inflammatory responsiveness on tumorigenesis in the mouse.Carcinogenesis, 19 2
Y. Shibata, S. Abe, S. Inoue, N. Takabatake, A. Igarashi, Y. Takeishi, M. Sata, I. Kubota (2008)
Altered expression of antimicrobial molecules in cigarette smoke‐exposed emphysematous mice lungsRespirology, 13
J. Samsom, A. Marel, L. Berkel, J. Helvoort, Y. Simons‐Oosterhuis, W. Jansen, M. Greuter, R. Nelissen, C. Meeuwisse, E. Nieuwenhuis, R. Mebius, G. Kraal (2007)
Secretory Leukoprotease Inhibitor in Mucosal Lymph Node Dendritic Cells Regulates the Threshold for Mucosal ToleranceThe Journal of Immunology, 179
A. Nakamura, Y. Mori, K. Hagiwara, Takuji Suzuki, Tomohiro Sakakibara, T. Kikuchi, T. Igarashi, M. Ebina, T. Abe, J. Miyazaki, T. Takai, T. Nukiwa (2003)
Increased Susceptibility to LPS-induced Endotoxin Shock in Secretory Leukoprotease Inhibitor (SLPI)-deficient MiceThe Journal of Experimental Medicine, 197
M. Eisen, P. Spellman, P. Brown, D. Botstein (1998)
Cluster analysis and display of genome-wide expression patterns.Proceedings of the National Academy of Sciences of the United States of America, 95 25
Weifeng Xu, B. He, A. Chiu, A. Chadburn, Meimei Shan, Malwina Buldys, A. Ding, D. Knowles, Paul Santini, A. Cerutti (2007)
Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPINature Immunology, 8
D. Goula, C. Benoist, S. Mantero, G. Merlo, G. Levi, G. Levi, B. Demeneix (1998)
Polyethylenimine-based intravenous delivery of transgenes to mouse lungGene Therapy, 5
C. Taggart, S. Cryan, S. Weldon, A. Gibbons, C. Greene, E. Kelly, T. Low, S. O’Neill, N. McElvaney (2005)
Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 bindingThe Journal of Experimental Medicine, 202
B. Py, S. Basmaciogullari, J. Bouchet, M. Zarka, I. Moura, M. Benhamou, R. Monteiro, H. Hocini, R. Madrid, S. Bénichou (2009)
The Phospholipid Scramblases 1 and 4 Are Cellular Receptors for the Secretory Leukocyte Protease Inhibitor and Interact with CD4 at the Plasma MembranePLoS ONE, 4
T. Nukiwa, Takuji Suzuki, T. Fukuhara, T. Kikuchi (2008)
Secretory leukocyte peptidase inhibitor and lung cancerCancer Science, 99
Maria Cekanova, Seong-ho Lee, R. Donnell, Mugdha Sukhthankar, T. Eling, S. Fischer, S. Baek (2009)
Nonsteroidal Anti-inflammatory Drug-Activated Gene-1 Expression Inhibits Urethane-Induced Pulmonary Tumorigenesis in Transgenic MiceCancer Prevention Research, 2
E. Hoskins, J. Rodriguez-Canales, S. Hewitt, Wafic Elmasri, Jasmine Han, Shin-Won Han, B. Davidson, E. Kohn (2011)
Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells.Gynecologic oncology, 122 3
西村 潤一 (2009)
Potent antimycobacterial activity of mouse secretory leukocyte protease inhibitor
Tatsuya Abé, Yasuyuki Tominaga, Toshiaki Kikuchi, Akira Watanabe, Ken Satoh, Yuji Watanabe, Toshihiro Nukiwa (1997)
Bacterial pneumonia causes augmented expression of the secretory leukoprotease inhibitor gene in the murine lung.American journal of respiratory and critical care medicine, 156 4 Pt 1
Jing Zhu, C. Nathan, W. Jin, Davis Sim, G. Ashcroft, S. Wahl, L. Lacomis, H. Erdjument-Bromage, P. Tempst, C. Wright, A. Ding (2002)
Conversion of Proepithelin to Epithelins Roles of SLPI and Elastase in Host Defense and Wound RepairCell, 111
(2004)
IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer
P. Forkert (2010)
Mechanisms of lung tumorigenesis by ethyl carbamate and vinyl carbamateDrug Metabolism Reviews, 42
T. Betsuyaku, K. Takeyabu, M. Tanino, M. Nishimura (2002)
Role of secretory leukocyte protease inhibitor in the development of subclinical emphysemaEuropean Respiratory Journal, 19
G. Stathopoulos, T. Sherrill, D. Cheng, R. Scoggins, W. Han, V. Polosukhin, L. Connelly, F. Yull, B. Fingleton, T. Blackwell (2007)
Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis.Proceedings of the National Academy of Sciences of the United States of America, 104 47
F. Osorio, Jorge Rosa, J. Freije (2013)
Luminescence-based in vivo monitoring of NF-κB activity through a gene delivery approachCell Communication and Signaling : CCS, 11
Ni Wang, T. Thuraisingam, L. Fallavollita, A. Ding, D. Radzioch, P. Brodt (2006)
The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response.Cancer research, 66 6
Daolong Wang, W. Lemon, M. You (2002)
Linkage disequilibrium mapping of novel lung tumor susceptibility quantitative trait loci in miceOncogene, 21
Secretory leukocyte protease inhibitor (SLPI), 11.7 kDa serine protease inhibitor, is produced primarily in the respiratory tract, but it is often elevated in lung, head/neck and ovarian cancers. SLPI expression in relation to cancer progression, metastasis and invasion has been studied extensively in non-small cell lung cancer. However, the role of SLPI during the early stages of carcinogenesis remains unknown. We hypothesized that SLPI is required from the initiation and promotion to the progression of lung carcinogenesis. A skin allograft model using SLPI-knockout (SLPI-KO) mice and short hairpin RNA-treated cells was used to demonstrate that SLPI expression in tumor cells is crucial for tumor formation. Moreover, lung tumorigenesis induced by urethane, a chemical lung carcinogen, was significantly suppressed in SLPI-KO mice in association with decreased nuclear factor-kappaB (NF-κB) activity. SLPI deficiency also resulted in decreased cell numbers and decreased production of inflammatory cytokines in bronchoalveolar lavage fluids. The suppression of NF-κB activation in SLPI-KO mice was associated with lower expression of NF-κB-related survival genes and DNA repair genes. Our findings demonstrate that SLPI plays an important role from the initial stages of lung carcinogenesis to the progression of lung cancer in an NF-κB-dependent manner.
Carcinogenesis – Oxford University Press
Published: Apr 26, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.